Evidence map›Paper›PMID 36225361›Full record

ReviewFrontiers in microbiology2022

Potential application of the probiotic

Hugo Ramirez-Olea, Bernardo Reyes-Ballesteros, Rocio Alejandra Chavez-Santoscoy

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Five-Day Treatment withNutrients · 2025
    Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Storage stability ofFrontiers in microbiology · 2026
    Article
  9. Article
  10. Genomic insights into the probiotic potential ofFrontiers in microbiology · 2026
    Article
  11. Elephant-derivedFrontiers in microbiology · 2026
    Article
  12. Hive-associated bacteria improve honeybee survival duringbioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. In Silico and In Vitro Characterization ofFoods (Basel, Switzerland) · 2025
    Article
  17. Review
  18. Article
  19. Frontiers in cellular and infection microbiology · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hugo Ramirez-OleaTecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Campus Monterrey, Monterrey, NL, Mexico.
Bernardo Reyes-BallesterosTecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Campus Estado de México, Ciudad López Mateos, MX, Mexico.
Rocio Alejandra Chavez-SantoscoyTecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Campus Monterrey, Monterrey, NL, Mexico.
Tecnológico de Monterrey · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of

Indexed as

adjuvant in treatmentanimal diseaseBacillus licheniformisfunctional ingredientshuman disease

Identifiers

PMID36225361
PMCPMC9549136
OpenAlexW4297229239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.